Overview

Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate the superiority of tiotropium compared to placebo in the treatment of patients with COPD and a concomitant diagnosis of asthma
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tiotropium Bromide